Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Tobacco Cessation Program for Rural Veterans With Comorbid Depression, Alcoholism or Obesity
Brief Summary: The proposed work is designed to help increase access to tobacco cessation services among rural veterans and to develop more effective treatment services that better address comorbid issues commonly experienced by rural smokers. The objectives are:

1. Study the feasibility of an individually-tailored telephone intervention for rural smokers.
2. Examine the impact of the intervention on tobacco use outcomes.
3. Evaluate the effect of the intervention on issues commonly experienced by rural smokers including depressive symptoms, alcohol use, and weight gain.


Options:
A: Arm Label: Product use sequence ABDC; Type: EXPERIMENTAL; Interventions: Other: Myblu flavor A_2.4, Other: Myblu flavor B_2.4, Other: Myblu flavor C_2.4, Other: Myblu flavor D_2.4 | Arm Label: Product use sequence BCAD; Type: EXPERIMENTAL; Interventions: Other: Myblu flavor A_2.4, Other: Myblu flavor B_2.4, Other: Myblu flavor C_2.4, Other: Myblu flavor D_2.4 | Arm Label: Product use sequence CDBA; Type: EXPERIMENTAL; Interventions: Other: Myblu flavor A_2.4, Other: Myblu flavor C_2.4, Other: Myblu flavor D_2.4 | Arm Label: Product use sequence DACB; Type: EXPERIMENTAL; Interventions: Other: Myblu flavor A_2.4, Other: Myblu flavor B_2.4, Other: Myblu flavor C_2.4, Other: Myblu flavor D_2.4 | Arm Label: Product use sequence EFHG; Type: EXPERIMENTAL; Interventions: Other: Myblu flavor E_1.2, Other: Myblu flavor F_1.2, Other: Myblu flavor G_2.4, Other: Myblu flavor H_2.4 | Arm Label: Product use sequence FGEH; Type: EXPERIMENTAL; Interventions: Other: Myblu flavor E_1.2, Other: Myblu flavor F_1.2, Other: Myblu flavor G_2.4, Other: Myblu flavor H_2.4 | Arm Label: Product use sequence GHFE; Type: EXPERIMENTAL; Interventions: Other: Myblu flavor E_1.2, Other: Myblu flavor F_1.2, Other: Myblu flavor G_2.4, Other: Myblu flavor H_2.4 | Arm Label: Product use sequence HEGF; Type: EXPERIMENTAL; Interventions: Other: Myblu flavor E_1.2, Other: Myblu flavor F_1.2, Other: Myblu flavor G_2.4, Other: Myblu flavor H_2.4 | Intervention Type: OTHER; Name: Myblu flavor A_2.4; Assigned to Arm(s): Product use sequence ABDC, Product use sequence BCAD, Product use sequence CDBA, Product use sequence DACB | Intervention Type: OTHER; Name: Myblu flavor B_2.4; Assigned to Arm(s): Product use sequence ABDC, Product use sequence BCAD, Product use sequence DACB | Intervention Type: OTHER; Name: Myblu flavor C_2.4; Assigned to Arm(s): Product use sequence ABDC, Product use sequence BCAD, Product use sequence CDBA, Product use sequence DACB | Intervention Type: OTHER; Name: Myblu flavor D_2.4; Assigned to Arm(s): Product use sequence ABDC, Product use sequence BCAD, Product use sequence CDBA, Product use sequence DACB | Intervention Type: OTHER; Name: Myblu flavor E_1.2; Assigned to Arm(s): Product use sequence EFHG, Product use sequence FGEH, Product use sequence GHFE, Product use sequence HEGF | Intervention Type: OTHER; Name: Myblu flavor F_1.2; Assigned to Arm(s): Product use sequence EFHG, Product use sequence FGEH, Product use sequence GHFE, Product use sequence HEGF | Intervention Type: OTHER; Name: Myblu flavor G_2.4; Assigned to Arm(s): Product use sequence EFHG, Product use sequence FGEH, Product use sequence GHFE, Product use sequence HEGF | Intervention Type: OTHER; Name: Myblu flavor H_2.4; Assigned to Arm(s): Product use sequence EFHG, Product use sequence FGEH, Product use sequence GHFE, Product use sequence HEGF
B: Arm Label: Nicotine Replacement Therapy Responder; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine Patches | Arm Label: Pre-Quit Rescue to Bupropion & Nicotine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patches, then bupropion & nicotine patches (Pre-Quit) | Arm Label: Pre-Quit Rescue to Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patches, then varenicline (Pre-Quit) | Arm Label: Pre-Quit Rescue to Nicotine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patches, then nicotine patches (Pre-Quit) | Arm Label: Post-Quit Rescue to Bupropion & Nicotine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patches, then bupropion & nicotine patches (Post-Quit) | Arm Label: Post-Quit Rescue to Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patches, then varenicline (Post-Quit) | Arm Label: Post-Quit Rescue to Nicotine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patches, then nicotine patches (Post-Quit) | Intervention Type: DRUG; Name: Nicotine Patches; Assigned to Arm(s): Nicotine Replacement Therapy Responder | Intervention Type: DRUG; Name: Nicotine patches, then bupropion & nicotine patches (Pre-Quit); Assigned to Arm(s): Pre-Quit Rescue to Bupropion & Nicotine | Intervention Type: DRUG; Name: Nicotine patches, then varenicline (Pre-Quit); Assigned to Arm(s): Pre-Quit Rescue to Varenicline | Intervention Type: DRUG; Name: Nicotine patches, then nicotine patches (Pre-Quit); Assigned to Arm(s): Pre-Quit Rescue to Nicotine | Intervention Type: DRUG; Name: Nicotine patches, then bupropion & nicotine patches (Post-Quit); Assigned to Arm(s): Post-Quit Rescue to Bupropion & Nicotine | Intervention Type: DRUG; Name: Nicotine patches, then varenicline (Post-Quit); Assigned to Arm(s): Post-Quit Rescue to Varenicline | Intervention Type: DRUG; Name: Nicotine patches, then nicotine patches (Post-Quit); Assigned to Arm(s): Post-Quit Rescue to Nicotine
C: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
D: Arm Label: Tailored Intervention Group; Type: EXPERIMENTAL; Interventions: Drug: Nicotine replacement therapy - transdermal nicotine patch, Behavioral: Tailored behavioral intervention, Drug: Nicotine replacement therapy - nicotine gum, Drug: Nicotine replacement therapy - nicotine lozenge, Drug: Bupropion Sustained Release, Drug: Varenicline, Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine gum, Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine lozenge, Drug: Combination pharmacotherapy - transdermal nicotine patch + bupropion, Behavioral: Alcohol use risk reduction, Behavioral: Behavioral activation for the treatment of depression, Behavioral: Behavioral management of post-cessation weight gain | Arm Label: Enhanced Standard of Care Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine replacement therapy - transdermal nicotine patch, Behavioral: Tobacco quit line referral, Drug: Nicotine replacement therapy - nicotine gum, Drug: Nicotine replacement therapy - nicotine lozenge, Drug: Bupropion Sustained Release, Drug: Varenicline, Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine gum, Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine lozenge, Drug: Combination pharmacotherapy - transdermal nicotine patch + bupropion | Intervention Type: DRUG; Name: Nicotine replacement therapy - transdermal nicotine patch; Assigned to Arm(s): Enhanced Standard of Care Group, Tailored Intervention Group | Intervention Type: BEHAVIORAL; Name: Tailored behavioral intervention; Assigned to Arm(s): Tailored Intervention Group | Intervention Type: BEHAVIORAL; Name: Tobacco quit line referral; Assigned to Arm(s): Enhanced Standard of Care Group | Intervention Type: DRUG; Name: Nicotine replacement therapy - nicotine gum; Assigned to Arm(s): Enhanced Standard of Care Group, Tailored Intervention Group | Intervention Type: DRUG; Name: Nicotine replacement therapy - nicotine lozenge; Assigned to Arm(s): Enhanced Standard of Care Group, Tailored Intervention Group | Intervention Type: DRUG; Name: Bupropion Sustained Release; Assigned to Arm(s): Enhanced Standard of Care Group, Tailored Intervention Group | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Enhanced Standard of Care Group, Tailored Intervention Group | Intervention Type: DRUG; Name: Combination pharmacotherapy - transdermal nicotine patch + nicotine gum; Assigned to Arm(s): Enhanced Standard of Care Group, Tailored Intervention Group | Intervention Type: DRUG; Name: Combination pharmacotherapy - transdermal nicotine patch + nicotine lozenge; Assigned to Arm(s): Enhanced Standard of Care Group, Tailored Intervention Group | Intervention Type: DRUG; Name: Combination pharmacotherapy - transdermal nicotine patch + bupropion; Assigned to Arm(s): Enhanced Standard of Care Group, Tailored Intervention Group | Intervention Type: BEHAVIORAL; Name: Alcohol use risk reduction; Assigned to Arm(s): Tailored Intervention Group | Intervention Type: BEHAVIORAL; Name: Behavioral activation for the treatment of depression; Assigned to Arm(s): Tailored Intervention Group | Intervention Type: BEHAVIORAL; Name: Behavioral management of post-cessation weight gain; Assigned to Arm(s): Tailored Intervention Group

Answer: D